Rocky Mountain Spotted Fever in a Large Metropolitan Center, Mexico–United States Border, 2009–2019
Oscar E. Zazueta
, Paige A. Armstrong, Adriana Márquez-Elguea, Néstor Saúl Hernández Milán, Amy E. Peterson, Diego F. Ovalle-Marroquín, Maria Fierro, Rodolfo Arroyo-Machado, Moises Rodriguez-Lomeli, Guillermo Trejo-Dozal, and Christopher D. Paddock
Author affiliations: Secretariat of Health of Baja California (Instituto de Servicios de Salud Pública del Estado de Baja California), Mexicali, Mexico (O.E. Zazueta, A. Márquez-Elguea, N.S.H. Milán, D.F. Ovalle-Marroquín, R. Arroyo-Machado, M. Rodriguez-Lomeli, G. Trejo-Dozal); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P.A. Armstrong, A.E. Peterson, C.D. Paddock); Imperial Country Public Health Department, El Centro, California, USA (M. Fierro)
Main Article
Figure 2
Figure 2. Incidence and mortality rates of laboratory-confirmed Rocky Mountain spotted fever, Mexicali, Mexico, 2009–2019. Scales for the y-axes differ substantially to underscore patterns but do not permit direct comparisons.
Main Article
Page created: April 15, 2021
Page updated: May 20, 2021
Page reviewed: May 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.